NASDAQ:BLUE
bluebird bio Stock News
$1.03
-0.0200 (-1.90%)
At Close: May 17, 2024
bluebird bio, Inc. (Nasdaq: BLUE) announced today that updated results from the pivotal Phase 2 KarMMa study evaluating the efficacy and safety of idecabtagene vicleucel (ide-cel; bb2121), an investig
bluebird bio Reports Updated Results From Pivotal Phase 2 KarMMa Study At ASCO 2020 Virtual Program
12:00am, Friday, 08'th May 2020Errant Gene Therapeutics (EGT) Wins Major Victory in New York Appeals Court
12:00am, Thursday, 07'th May 2020
Errant Gene Therapeutics (EGT) Wins Major Victory in New York Appeals Court
Better Buy: Crispr Therapeutics vs. bluebird bio
10:27am, Thursday, 30'th Apr 2020
Who wins in a matchup between these two gene-editing leaders?
bluebird bio Announces First Quarter 2020 Earnings Conference Call and May Investor Event
12:01pm, Wednesday, 29'th Apr 2020
CAMBRIDGE, Mass. — bluebird bio, Inc. (NASDAQ: BLUE) today announced it will hold a conference call to discuss first quarter 2020 financial results and business updates on Monday, May 11 at 8…
bluebird bio Announces First Quarter 2020 Earnings Conference Call and May Investor Event
12:00pm, Wednesday, 29'th Apr 2020
bluebird bio, Inc. (NASDAQ: BLUE) today announced it will hold a conference call to discuss first quarter 2020 financial results and business updates on Monday, May 11 at 8:00 am ET.
How These 15 Stock Suggestions Fared Against the Market
04:44pm, Tuesday, 28'th Apr 2020
Motley Fool co-founder David Gardner revisits three Five-Stock Samplers and offers up lessons he learned to help you invest better.
Blue Light Radiation Emitted from Mobile Phones Can Damage Your Skin
04:06am, Tuesday, 28'th Apr 2020
Another thing to worry about: Using our digital devices can cause great damage to our skin because of blue light.
Stop Making Sense
01:28pm, Monday, 27'th Apr 2020
Not everything will make sense to everyone all of the time. Bear arguments make sense. Bull arguments make sense. The market will do what it will do. Set aside
Another Good Week for Biopharma and Diagnostics Stocks: Innovation is Driving Gains
08:05am, Monday, 27'th Apr 2020
As the market moves with COVID epidemiological data many stocks took a hit on questionable or incomplete news from the WHO on a clinical study in China on Remdesivir; Gilead Sciences stock took a hit
Ingalls & Snyder LLC Lowers Position in bluebird bio Inc (NASDAQ:BLUE)
09:36am, Saturday, 25'th Apr 2020
Ingalls & Snyder LLC cut its stake in shares of bluebird bio Inc (NASDAQ:BLUE) by 8.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor own
bluebird bio (NASDAQ:BLUE) Upgraded to Sell at BidaskClub
06:32am, Saturday, 25'th Apr 2020
BidaskClub upgraded shares of bluebird bio (NASDAQ:BLUE) from a strong sell rating to a sell rating in a research note issued to investors on Tuesday morning, BidAskClub reports. A number of other res
